Insights & Resources

Wyoming House Bill 11 expands the manufacturing sales and use tax exemptions. We break down what this means for businesses operating in Wyoming.

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

Explore the top five impacts tariffs may have on your business taxes and learn steps and key strategies to manage costs, credits and compliance.

Texas’ direct pay permits can streamline tax compliance, improve cash flow and reduce costs for oil and gas companies.

The National Association of Manufacturers (NAM) has released its Q4 Manufacturers’ Survey. Learn more about what it means for leadership in 2025.

In the oil and gas industry, an asset might be sold outright or as a disregarded entity, which is treated the same for federal income tax purposes.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

Received a Schedule K-1 with upstream oil income? Learn the five key steps to ensure accurate reporting, including deductions for IDC, depletion and asset sales.

With 2024 coming to a close, time is running out for manufacturing companies to take advantage of many year-end tax benefits.

Learn about depletion deductions for oil & gas investors. Understand percentage and cost depletion, key tax benefits and the impact on taxable income.

IRS Notice 2024-52 confirmed the Marginal Well Credit applies in 2024, offering $0.77 per Mcf for qualified natural gas from marginal wells.

Shale maturation and technological innovation impact IP valuations, influencing long-term asset value and productivity in the oil and gas industry.